Tianjin Medical University Cancer Institute and Hospital: Esophageal Neoplasms trials

The registry lists 20 Esophageal Neoplasms studies with Tianjin Medical University Cancer Institute and Hospital as lead sponsor. 7 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 13Phase 3 3No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCCRecruitingNCT07733830Phase 2
• dCRT vs. Surgery in Resectable ESCC Patients Achieving cCR/PR After Induction ChemoimmunotherapyRecruitingNCT07162506Phase 2
• Chemoradiation Plus Iparomlimab Consolidation in Older With ESCCRecruitingNCT07038629Phase 2
• Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.RecruitingNCT06452602Phase 2
• Tislelizumab Plus Concurrent Chemoradiation in Older With ESCCRecruitingNCT06061146Phase 2
• A Multicenter, Cross-sectional Study on the Quality of Life in Long-term Survival Esophageal Cancer Patients After Radical Radiochemotherapy/RadiotherapyNot yet recruitingNCT05828875
• Carrelizumab Combined With Chemotherapy for Adjuvant Therapy of Esophageal Squamous Cell CarcinomaRecruitingNCT05637268Phase 2
• Concentrated Complex Plant Dietary Elements for Chemotherapy-Induced DiarrheaCompletedNCT07460596Phase 2
• Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at RiskCompletedNCT05787522
• Neoadjuvant Therapy of Camrelizumab Combined With Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT05476380Phase 2
• Visualization Versus Intraoperative Neuromonitoring of the Recurrent Laryngeal Nerves During Thoracoscopic EsophagectomyStatus unknownNCT05199168Not applicable
• A One-arm, Prospective Study Comparing the Effects of Different Body Composition on the Survival of Patients Undergoing Radical Concurrent Chemoradiotherapy for Esophageal CancerStatus unknownNCT04936750
• Pembrolizumab Plus Neoadjuvant Chemotherapy for Locally Advanced EGJ AdenocarcinomaStatus unknownNCT04813523Phase 2
• Efficacy and Safety of Neo-CRT Followed Surgery Compared With Definitive CRT in Patients With Initial Unresectable ESOStatus unknownNCT04137679Phase 2
• A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal CancerStatus unknownNCT03708042Phase 3
• Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCCStatus unknownNCT03671265Not applicable
• Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESCStatus unknownNCT03366883Phase 3
• An Exploratory Clinical Study of Apatinib for the 2nd Treatment of Esophageal Cancer or Esophageal and GastricStatus unknownNCT03285906Phase 2/3
• A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal CancerStatus unknownNCT02959385Phase 2
• Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal CancerStatus unknownNCT02762474Phase 1/2